10.1002/chem.201700466
Chemistry - A European Journal
COMMUNICATION
highly organized chair-like transition state. Use of the chiral (S)-
tBuPhox ligand in reactions of achiral substrates 22a-b provides
products with up to 98.5:1.5 er. Future studies will be directed
towards further expanding the scope of these reactions to a
broader array of nucleophiles, and to afford a variety of different
carbocyclic systems.
derivatives and exogenous alkenes, see: c) T. Piou, T. Rovis, Nature, 2015,
527, 86.
[9] For reviews on stereochemical pathways of Pd-catalyzed nucleopalladation,
see: a) K. H. Jensen, M. S. Sigman, Org. Biomol. Chem. 2008, 6, 4083; b) R. I.
McDonald, G. Liu, S. S. Stahl, Chem. Rev. 2011, 111, 2981; c) P. Kočovský,
J.-E. Bäckvall, Chem. Eur. J. 2015, 21, 36.
[ 10 ]
A
previous enantioselective synthesis of indanes via C(sp2)-H
functionalization was reported which utilized alkenyl triflates and a Pd-catalyst:
M. R. Albicker, N. Cramer, Angew. Chem. Int. Ed. 2009, 48, 9139; Angew.
Chem. 2009, 121, 9303.
[11] For a review on the synthesis of indane systems, see: B.-C. Hong, S.
Sarshar, Org. Prep. Proc. Int. 1999, 31, 1.
Acknowledgements
[12] D. L. Comins, A. Dehghani, Tetrahedron Lett. 1992, 33, 6299.
[13] Attempts to decrease reaction temperature or catalyst loading (to 0.5
mol % Pd) through use of the Buchwald Brettphos precatalyst have thus far
been unsuccessful.
The authors thank the University of Michigan for financial
support of this work. DRW’s studies were also supported in part
by a Bristol Myers Squibb Graduate Research Fellowship, for
which he is grateful.
[14] Products resulting from a reaction between the secondary amine product
and
a second equivalent of alkenyl triflate were not observed in
transformations of primary amine nucleophiles.
[15] See the Supporting Information for details of optimization studies.
[16] a) L. J. El-Naggar, J. L. Beal, J. Nat. Prod. 1980, 43(6), 649; b) B. M.
Trost, M. K.-T. Mao, J. M. Balkovec, P. Buhlmayer, J. Am. Chem. Soc. 1986,
108, 4965; c) S. Isoe, Stud. Nat. Prod. Chem. 1995, 16, 289; d) B. Dinda, S.
Debnath, Y. Harigaya, Chem. Pharm. Bull. 2007, 55, 159; e) F. Geu-Flores, N.
H. Sherdan, V. Courdavault, V. Burlat, W. S. Glenn, C. Wu, E. Nims, Y. Cui, S.
E. O’Connor, Nature 2012, 492, 138; f) R. S. S. Barreto, R. L. C. Albuquerque-
Júnior, A. A. S. Araújo, J. R. G. S. Almeida, M. R. V. Santos, A. S. Barreto, J.
M. DeSantana, P. S. Siqueira-Lima, J. S. S. Quintas, L. J. Quintans-Júnior,
Molecules 2014, 19, 846.
[ 17] For previous reports on passenger strategies and the use of bis-
electrophiles, see: a) J. E. Macor, R. J. Ogilvie, M. J. Wythes, Tetrahedron Lett.
1996, 37, 4289; b) S. Bräse, Synlett 1999, 10, 1654; c) S. J. Byrne, A. J.
Fletcher, P. Hebeisen, M. C. Willis, Org. Biomol. Chem. 2010, 8, 758.
[18] Products resulting from competing N-arylation of the substrate were not
observed.
Keywords: stereoselective synthesis • asymmetric catalysis •
enantioselective synthesis • carbocycle • palladium
References
[1] a) H. Aizawa, M. Seki, J.-I. Endoh, M. Tanaka, N. Fujie, O. Sakuma, T.
Kamahori. Novel Nitrogenated Heterocyclic Compound. EP 1,939,183 A1,
June 25, 2006; b) S. Kothandaraman, K. L. Donnely, G. Butora, R. Jiao, A.
Pasternak, G. J. Morriello, S. D. Goble, C. Zhou, S. G. Mills, M. MacCoss, P. P.
Vicario, J. M. Ayala, J. A. DeMartino, M. Struthers, M. A. Cascieri, L. Yang,
Bioorg. Med. Chem. Lett. 2009, 19, 1830; c) C. Tsaklakidis, W. Staehle, B.
Leuthner, P. Czodrowski. 3-Aminocyclopentane carboxamide derivatives. WO
2014/075754, Oct. 17, 2013; d) M. Vilums, A. J. M. Zweemer, Z. Yu, H. de
Vries, J. M. Hillger, H. Wapenaar, I. A. E. Bollen, F. Barmare, R. Gross, J.
Clemens, P. Krenitsky, J. Brussee, D. Stamos, J. Saunders, L. H. Heitman, A.
P. Ijzerman, J. Med. Chem. 2013, 56, 7706; e) A. S. Khile, V. Nair, N. Trivedi,
N. S. Pradhan. Process for Preparing Cyclopentylamine Derivatives and
Intermediates Thereof. US 2014/0206867 A1, July 24, 2014. f) X. Zhang, Q.
Dong, B. Liu, Y. Zhu, X. Li, J. Lan. Pyrrole Six-Membered Heteroaryl Ring
Derivative, Preparation Method Thereof, and Medicinal Uses Therof. US
20114/0336207 A1, Nov. 13, 2014.
[19] The two stereoisomers appear to both have a trans relationship between
the amino group and the phenyl group but are epimeric at the ring-fusion
stereocenter.
[2] a) Y. Sudhaker Babu, P. Chand, S. Bantia, P. Kotian, A. Dehghani, Y. El-
Kattan, T.-H. Lin, T. L. Hutchison, A. J. Elliott, C. D. Parker, S. L. Ananth, L. L.
Horn, G. W. Laver, J. A. Montgomery, J. Med. Chem. 2000, 43(19) , 3482; b)
S.-K. Leang, S. Kwok, S. G. Sullivan, S. Maurer-Stroh, A. Kelso, I. G. Barr, A.
C. Hurt, Influenza Other Respir. Viruses 2014, 8, 135; c) S. Y. Babu.
Substituted Cyclopentane and Cyclopentene Compounds Useful as
Neuroaminidase Inhibitors. WO 99/33781, July 8, 1999; d) P. Chen, Y. Li, S.
Peng, S. Jiang, Z. Cai, R. An, W. Wang, X. Dong. A Novel Process for the
Preparation of Peramavir and Intermediates Thereof. WO 2012/145932 A1,
April 29, 2011.
[3] a) G. S. Bisacchi, S. T. Chao, C. Bachard, J. P. Daris, S. Innaimo, G. A.
Jacobs, O. Kocy, P. Lapointe, A. Martel, Z. Merchant, W. A. Slusarchyk, J. E.
Sundeen, M. G. Young, R. Colonno, R. Zahler, Bioorg. Med. Chem. Lett. 1997,
7(2), 127; b) K. A. Sims, A. M. Woodland, Pharmacotherapy 2006, 26(12),
1745; c) L. J. Scott, G. M. Keating, Drugs 2009, 69(8), 1003; d) Y.-J. Sheng,
J.-Y. Liu, S.-W. Tong, H.-D. Hu, D.-Z. Zhang, P. Hu, H. Ren, Virol. J. 2011, 8,
393.
[4] L. S. Jeong, J. A. Lee, Antivir. Chem. Chemother. 2004, 15, 235.
[5] M. D. McBriar, H. Guzik, S. Shapiro, J. Paruchova, R. Xu, A. Palani, J. W.
Clader, K. Cox, W. J. Greenlee, B. E. Hawes, T. J. Kowalski, K. O’Neill, B. D.
Spar, B. Weig, D. J. Weston, C. Farley, J. Cook, J. Med. Chem. 2006, 49,
2294.
[6] Y. Okumura, A. Ando, R. W. Stevens, M. Shimizu, Tetrahedron 2002, 58,
8729.
[7] D. R. White, J. T. Hutt, J. P. Wolfe, J. Am. Chem. Soc. 2015, 137(35),
11246.
[8] Alkene carboaminations that do not involve alkenes bearing pendant
nucleophiles are rare. For examples of Pd-catalyzed alkene carboaminations
between 2-bromoanilines and exogenous alkenes, see: a) V. Bizet, G. M.
Gorrajo-Calleja, C. Besnard, C. Mazet, ACS Catal. 2016, 6, 7183. For
examples of Pd-catalyzed carboamination reactions between N-
fluorobenzenesulfonamide and exogenous alkenes, see: b) K. Kaneko, T.
Yoshino, S. Matsunaga, M. Kanai, Org. Lett. 2013, 15, 2502. For examples of
Rh-catalyzed carboamination reactions between N-enoxyphthalimide
This article is protected by copyright. All rights reserved.